157 related articles for article (PubMed ID: 12434995)
1. Long-term graft survival with or without donor-specific transfusion in cyclosporine era in one haplo-identical living-related renal transplant recipients beyond the first year: a 19-year experience.
Satoh S; Sugimura J; Omori S; Seino K; Fujizuka I
Tohoku J Exp Med; 2002 Aug; 197(4):201-7. PubMed ID: 12434995
[TBL] [Abstract][Full Text] [Related]
2. Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients.
Sharma RK; Rai PK; Kumar A; Kumar P; Gupta A; Kher V; Agrawal S; Bhandari M
Nephron; 1997; 75(1):20-4. PubMed ID: 9031265
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
[TBL] [Abstract][Full Text] [Related]
4. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
Flye MW; Burton K; Mohanakumar T; Brennan D; Keller C; Goss JA; Sicard GA; Anderson CB
Transplantation; 1995 Dec; 60(12):1395-401. PubMed ID: 8545863
[TBL] [Abstract][Full Text] [Related]
5. Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood.
Amada N; Okazaki H; Sato T; Ohashi Y; Kikuchi H
Transplant Proc; 2005 Mar; 37(2):927-9. PubMed ID: 15848577
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
7. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
8. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
9. Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens.
Leivestad T; Albrechtsen D; Flatmark A; Thorsby E
Transplantation; 1986 Jul; 42(1):35-8. PubMed ID: 3523880
[TBL] [Abstract][Full Text] [Related]
10. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL
Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244
[TBL] [Abstract][Full Text] [Related]
11. Living-donor renal transplantation in SEOPF. The impact of histocompatibility, transfusions, and cyclosporine on outcome.
Sanfilippo F; Thacker L; Vaughn WK
Transplantation; 1990 Jan; 49(1):25-9. PubMed ID: 2301022
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of donor-specific blood transfusion with cyclosporine in living related kidney transplantation.
Otsuka M; Yuzawa K; Takada Y; Taniguchi H; Todoroki K; Fukao K; Koyama A; Akaza H
Nephron; 2001 Jun; 88(2):144-8. PubMed ID: 11399917
[TBL] [Abstract][Full Text] [Related]
13. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
14. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
[TBL] [Abstract][Full Text] [Related]
15. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
[TBL] [Abstract][Full Text] [Related]
16. Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era.
Marti HP; Henschkowski J; Laux G; Vogt B; Seiler C; Opelz G; Frey FJ
Transpl Int; 2006 Jan; 19(1):19-26. PubMed ID: 16359373
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group.
Alexander JW; Light JA; Donaldson LA; Delmonico FL; Diethelm AG; Wilkinson A; Rosenthal JT; Thistlethwaite JR; Hunsicker LG; Matas AJ; First MR; Reinsmoen NL; Rose SM
Transplantation; 1999 Oct; 68(8):1117-24. PubMed ID: 10551639
[TBL] [Abstract][Full Text] [Related]
18. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
19. Long-term results with cyclosporine monotherapy in renal transplant patients: a multivariate analysis of risk factors.
Montagnino G; Tarantino A; Maccario M; Elli A; Cesana B; Ponticelli C
Am J Kidney Dis; 2000 Jun; 35(6):1135-43. PubMed ID: 10845828
[TBL] [Abstract][Full Text] [Related]
20. Long-term graft survival of living-related kidneys after donor-specific transfusion.
Otsuka M; Yuzawa K; Takada Y; Taniguchi H; Fukunaga K; Seino K; Todoroki T; Fukao K
Transplant Proc; 2000 Nov; 32(7):1741-2. PubMed ID: 11119914
[No Abstract] [Full Text] [Related]
[Next] [New Search]